Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases

HPB

Volumn 17, Issue 6, 2015, Pages 529-535

  Spelt, Lidewij ^a   Sparrelid, Ernesto ^b   Isaksson, Bengt ^b   Andersson, Roland G ^a   Sturesson, Christian ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; ENBUCRILATE; ERLOTINIB; IRINOTECAN; OXALIPLATIN; PANITUMUMAB; POLYVINYL ALCOHOL;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SIZE; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEMIHEPATECTOMY; HUMAN; INTRAOPERATIVE PERIOD; LIVER LOBE; MALE; MULTIPLE CYCLE TREATMENT; PORTAL VEIN EMBOLIZATION; PRACTICE GUIDELINE; PREOPERATIVE CARE; VERY ELDERLY; ADJUVANT CHEMOTHERAPY; ADVERSE EFFECTS; CELL PROLIFERATION; CHEMOEMBOLIZATION; CLINICAL TRIAL; COLORECTAL TUMOR; DIAGNOSTIC IMAGING; DISEASE COURSE; LIVER NEOPLASMS; LIVER RESECTION; MIDDLE AGED; MULTICENTER STUDY; NEOADJUVANT THERAPY; PATHOLOGY; PORTAL VEIN; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY; STATISTICAL MODEL; SWEDEN; TIME FACTOR; TREATMENT OUTCOME; TUMOR VOLUME; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; CELL PROLIFERATION; CHEMOEMBOLIZATION, THERAPEUTIC; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HEPATECTOMY; HUMANS; LINEAR MODELS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PORTAL VEIN; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84929267087     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12397     Document Type: Article

References (33)

1. Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G,. (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93: 465-474.
2. Pawlik TM, Schulick RD, Choti MA,. (2008) Expanding criteria for resectability of colorectal liver metastases. Oncologist 13: 51-64.
3. Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG, et al,. (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237: 686-691; discussion 91-3.
4. Pamecha V, Glantzounis G, Davies N, Fusai G, Sharma D, Davidson B,. (2009) Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases. Ann Surg Oncol 16: 1202-1207.
5. Fujii Y, Shimada H, Endo I, Kamiyama M, Kamimukai N, Tanaka K, et al,. (2000) Changes in clinicopathological findings after portal vein embolization. Hepatogastroenterology 47: 1560-1563.
6. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, et al,. (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34: 267-272.
7. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al,. (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371: 1007-1016.
8. Gruenberger B, Tamandl D, Schueller J, Scheithauer W, Zielinski C, Herbst F, et al,. (2008) Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol 26: 1830-1835.
9. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, et al,. (2004) Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 240: 1052-1061; discussion 61-4.
10. Vigano L, Capussotti L, Barroso E, Nuzzo G, Laurent C, Ijzermans JN, et al,. (2012) Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases. Ann Surg Oncol 19: 2786-2796.
11. Hoekstra LT, van Lienden KP, Doets A, Busch OR, Gouma DJ, van Gulik TM,. (2012) Tumor progression after preoperative portal vein embolization. Ann Surg 256: 812-817; discussion 7-8.
12. Pamecha V, Levene A, Grillo F, Woodward N, Dhillon A, Davidson BR,. (2009) Effect of portal vein embolisation on the growth rate of colorectal liver metastases. Br J Cancer 100: 617-622.
13. Fischer C, Melstrom LG, Arnaoutakis D, Jarnagin W, Brown K, D'Angelica M, et al,. (2013) Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy. JAMA Surg 148: 1103-1108.
14. Pommier R, Ronot M, Cauchy F, Gaujoux S, Fuks D, Faivre S, et al,. (2014) Colorectal liver metastases growth in the embolized and non-embolized liver after portal vein embolization: influence of initial response to induction chemotherapy. Ann Surg Oncol 21: 3077-3083.
15. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al,. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45: 228-247.
16. Couinaud C,. (1957) Le Foie. Etudes anatomiques et chirurgicales. Paris: Masson & Cie.
17. Sturesson C, Keussen I, Tranberg KG,. (2010) Prolonged chemotherapy impairs liver regeneration after portal vein occlusion-an audit of 26 patients. Eur J Surg Oncol 36: 358-364.
18. Sturesson C, Nilsson J, Eriksson S, Spelt L, Andersson R,. (2013) Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases. HPB 15: 646-652.
19. Simoneau E, Aljiffry M, Salman A, Abualhassan N, Cabrera T, Valenti D, et al,. (2012) Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. HPB 14: 461-468.
20. Narita M, Oussoultzoglou E, Jaeck D, Fuchschuber P, Rosso E, Pessaux P, et al,. (2011) Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br J Surg 98: 1463-1475.
21. Lam VW, Laurence JM, Johnston E, Hollands MJ, Pleass HC, Richardson AJ,. (2013) A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. HPB 15: 483-491.
22. Lim C, Farges O,. (2012) Portal vein occlusion before major hepatectomy in patients with colorectal liver metastases: rationale, indications, technical aspects, complications and outcome. J Visc Surg 149: e86-e96.
23. Tschuor C, Croome KP, Sergeant G, Cano V, Schadde E, Ardiles V, et al,. (2013) Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion-an extension of the ALPPS approach. Eur J Surg Oncol 39: 1230-1235.
24. Bischof DA, Clary BM, Maithel SK, Pawlik TM,. (2013) Surgical management of disappearing colorectal liver metastases. Br J Surg 100: 1414-1420.
25. Arita J, Ono Y, Takahashi M, Inoue Y, Takahashi Y, Saiura A,. (2014) Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy. Ann Surg Oncol 21 (Suppl 3): S390-S397.
26. de Baere T, Teriitehau C, Deschamps F, Catherine L, Rao P, Hakime A, et al,. (2010) Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol 17: 2081-2089.
27. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN,. (2007) Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94: 1386-1394.
28. Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S, et al,. (2008) Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 247: 451-455.
29. de Baere T, Denys A, Paradis V,. (2009) Comparison of four embolic materials for portal vein embolization: experimental study in pigs. Eur Radiol 19: 1435-1442.
30. Guiu B, Bize P, Gunthern D, Demartines N, Halkic N, Denys A,. (2013) Portal vein embolization before right hepatectomy: improved results using n-butyl-cyanoacrylate compared to microparticles plus coils. Cardiovasc Intervent Radiol 36: 1306-1312.
31. Denys AL, Abehsera M, Leloutre B, Sauvanet A, Vilgrain V, O'Toole D, et al,. (2000) Intrahepatic hemodynamic changes following portal vein embolization: a prospective Doppler study. Eur Radiol 10: 1703-1707.
32. Yokoyama Y, Nagino M, Nimura Y,. (2007) Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg 31: 367-374.
33. Archer SG, Gray BN,. (1989) Vascularization of small liver metastases. Br J Surg 76: 545-548.